Evidence map›Paper›PMID 26939538›Full record

ArticleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2016

Virological surveillance of influenza and other respiratory viruses during six consecutive seasons from 2006 to 2012 in Catalonia, Spain.

A Antón, M A Marcos, N Torner, R Isanta, M Camps, A Martínez, A Domínguez, M Jané, M T Jiménez de Anta, T Pumarola

Open access · bronzeAbstract read
In one paragraph

Article in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

A AntónWHO National Influenza Centre, Faculty of Medicine, University of Barcelona, Barcelona, Spain; Department of Clinical Microbiology, Hospital Clinic Barcelona - ISGlobal - University of Barcelona, Barcelona, Spain. Electronic address: aanton76@gmail.com.
M A MarcosWHO National Influenza Centre, Faculty of Medicine, University of Barcelona, Barcelona, Spain; Department of Clinical Microbiology, Hospital Clinic Barcelona - ISGlobal - University of Barcelona, Barcelona, Spain.
N TornerPublic Health Agency of Catalonia, Government of Catalonia, Barcelona, Spain; Public Health Department, Faculty of Medicine, University of Barcelona, Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
R IsantaWHO National Influenza Centre, Faculty of Medicine, University of Barcelona, Barcelona, Spain; Department of Clinical Microbiology, Hospital Clinic Barcelona - ISGlobal - University of Barcelona, Barcelona, Spain.
M CampsWHO National Influenza Centre, Faculty of Medicine, University of Barcelona, Barcelona, Spain; Department of Clinical Microbiology, Hospital Clinic Barcelona - ISGlobal - University of Barcelona, Barcelona, Spain.
A MartínezPublic Health Agency of Catalonia, Government of Catalonia, Barcelona, Spain; Public Health Department, Faculty of Medicine, University of Barcelona, Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
A DomínguezPublic Health Agency of Catalonia, Government of Catalonia, Barcelona, Spain; Public Health Department, Faculty of Medicine, University of Barcelona, Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
M JanéPublic Health Agency of Catalonia, Government of Catalonia, Barcelona, Spain.
M T Jiménez de AntaWHO National Influenza Centre, Faculty of Medicine, University of Barcelona, Barcelona, Spain; Department of Clinical Microbiology, Hospital Clinic Barcelona - ISGlobal - University of Barcelona, Barcelona, Spain.
T PumarolaWHO National Influenza Centre, Faculty of Medicine, University of Barcelona, Barcelona, Spain; Department of Clinical Microbiology, Hospital Clinic Barcelona - ISGlobal - University of Barcelona, Barcelona, Spain.
Hospital Clínic de Barcelona · ESGeneralitat de Catalunya · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most attention is given to seasonal influenza and respiratory syncytial virus outbreaks, but the cumulative burden caused by other respiratory viruses (RV) is not widely considered. The aim of the present study is to describe the circulation of RV in the general population during six consecutive seasons from 2006 to 2012 in Catalonia, Spain. Cell culture, immunofluorescence and PCR-based assays were used for the RV laboratory-confirmation and influenza subtyping. Phylogenetic and molecular characterizations of viral haemagglutinin, partial neuraminidase and matrix 2 proteins were performed from a representative sampling of influenza viruses. A total of 6315 nasopharyngeal samples were collected, of which 64% were laboratory-confirmed, mainly as influenza A viruses and rhinoviruses. Results show the significant burden of viral aetiological agents in acute respiratory infection, particularly in the youngest cases. The study of influenza strains reveals their continuous evolution through either progressive mutations or by segment reassortments. Moreover, the predominant influenza B lineage was different from that included in the recommended vaccine in half of the studied seasons, supporting the formulation and use of a quadrivalent influenza vaccine. Regarding neuraminidase inhibitors resistance, with the exception of the 2007/08 H275Y seasonal A(H1N1) strains, no other circulating influenza strains carrying known resistance genetic markers were found. Moreover, all circulating A(H1N1)pdm09 and A(H3N2) strains finally became genetically resistant to adamantanes. A wide knowledge of the seasonality patterns of the RV in the general population is well-appreciated, but it is a challenge due to the unpredictable circulation of RV, highlighting the value of local and global RV surveillance.

Indexed as

AdolescentAdultAgedChildChild, PreschoolEpidemiological MonitoringEvolution, MolecularFemaleFluorescent Antibody TechniqueHumansInfantMaleMiddle AgedMolecular EpidemiologyNasopharynxPolymerase Chain ReactionInfluenza virusesmolecular epidemiologyrespiratory syncytial virusrespiratory virusessurveillancetype/subtype/lineage

Identifiers

PMID26939538
PMCPMC7172104
OpenAlexW2288880263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.